Published in Asian J Androl on November 04, 2014
Prostate-cancer mortality at 11 years of follow-up. N Engl J Med (2012) 16.91
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst (2012) 11.91
Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin (2007) 5.67
Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan. Asian J Androl (2014) 0.93
Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol (2010) 4.45
A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group. J Urol (2011) 1.84
Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis. Int J Cancer (2008) 1.73
The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study. Eur Urol (2007) 1.62
The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort study. BJU Int (2008) 1.53
A pilot study combining a GC-sensor device with a statistical model for the identification of bladder cancer from urine headspace. PLoS One (2013) 1.51
Is it time to re-design the haematuria clinic? BJU Int (2009) 1.46
HDR Brachytherapy in the Management of High-Risk Prostate Cancer. Adv Urol (2012) 1.45
Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway? J Magn Reson Imaging (2012) 1.18
Sildenafil inhibits the formation of superoxide and the expression of gp47 NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells. BJU Int (2005) 1.10
Antibiotics for transrectal ultrasonography-guided prostate biopsy: are we practising evidence-based medicine? BJU Int (2008) 1.06
Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats. BJU Int (2009) 0.98
Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits. Eur J Pharmacol (2005) 0.95
Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study. Int J Cancer (2004) 0.90
Fibronectin confers survival against chemotherapeutic agents but not against radiotherapy in DU145 prostate cancer cells: involvement of the insulin like growth factor-1 receptor. Prostate (2010) 0.88
Dihydrotestosterone sensitises LNCaP cells to death induced by epigallocatechin-3-Gallate (EGCG) or an IGF-I receptor inhibitor. Prostate (2009) 0.87
Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia. BJU Int (2013) 0.87
Macroscopic haematuria and urological cancer. Br J Gen Pract (2003) 0.86
The administration of folic acid improves erectile function and reduces intracavernosal oxidative stress in the diabetic rabbit. BJU Int (2008) 0.85
Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation in the corpus cavernosum in the rabbit. BJU Int (2006) 0.85
Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation and superoxide formation in the aorta of the rabbit. Eur J Pharmacol (2006) 0.83
The role of hexylaminolaevulinate in the diagnosis and follow-up of non-muscle-invasive bladder cancer. BJU Int (2010) 0.83
Homocysteine and copper interact to promote type 5 phosphodiesterase expression in rabbit cavernosal smooth muscle cells. Asian J Androl (2008) 0.83
The trends in prostate specific antigen usage amongst United Kingdom urologists--a questionnaire based study. BMC Urol (2008) 0.83
Differences in the epidemiology and presentation of prostate cancer in Black and White men in England: lessons learnt from the process study. BJU Int (2008) 0.81
Incidence of prostate cancer in Sri Lanka using cancer registry data and comparisons with the incidence in South Asian men in England. BJU Int (2011) 0.80
Is the therapeutic action of sildenafil mediated partly through the inhibition of superoxide formation? BJU Int (2005) 0.78
Incidence of bladder cancer in sri lanka: analysis of the cancer registry data and review of the incidence of bladder cancer in the South asian population. Korean J Urol (2012) 0.78
Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening. Urology (2004) 0.78
Smoking and erectile dysfunction: the role of NADPH oxidase. BJU Int (2004) 0.77
Re: Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants. J Urol (2006) 0.77
Cavernosal dysfunction in a rabbit model of hyperhomocysteinaemia. BJU Int (2005) 0.77
Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms. BJU Int (2006) 0.76
Benign prostatic hyperplasia and sexual dysfunction. Lancet (2003) 0.75
Re: prostate cancer detection with office based saturation biopsy in a repeat biopsy population. J Urol (2005) 0.75
Re: alfuzosin once daily facilitates return to voiding in patients in acute urinary retention. J Urol (2005) 0.75
The use of a gas chromatography-sensor system combined with advanced statistical methods, towards the diagnosis of urological malignancies. J Breath Res (2016) 0.75
Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int (2009) 0.75
Sexual dysfunction and cardiac risk (the second Princeton Concensus Conference). Am J Cardiol (2005) 0.75
Prostate cancer survivorship and psychosexual care. Eur J Cancer Care (Engl) (2015) 0.75
High-intensity focused ultrasound (HIFU) for treating prostate cancer. BJU Int (2005) 0.75
Optimizing the diagnosis of prostate cancer in high-risk men: the supplementary biomarker approach. BJU Int (2005) 0.75
Do we need to obtain consent for penile shortening as a complication of treatment for organ-confined prostate cancer? BJU Int (2012) 0.75
Radiotherapy and surgery for high-risk localized prostate cancer: a UK questionnaire survey of urologists and clinical oncologists. BJU Int (2012) 0.75
Assessment of a combined gas chromatography mass spectrometer sensor system for detecting biologically relevant volatile compounds. J Breath Res (2017) 0.75
Photodynamic diagnostic cystoscopy. BJU Int (2012) 0.75
Patient fitness for therapy, a missing element. Eur J Cancer Care (Engl) (2015) 0.75
Prostate cancer survivorship: lifestyle changes, much needed! World J Urol (2014) 0.75
Retroperitoneoscopic nephrectomy for pelvic kidney. Surg Laparosc Endosc Percutan Tech (2007) 0.75
Bladder carcinoma in situ (CIS) in Australia: a rising incidence for an under-reported malignancy. BJU Int (2013) 0.75